CoChat

Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease

Open access
Morenas-Rodríguez, Estrella, Alcolea, Daniel, Suárez-Calvet, Marc, Muñoz-Llahuna, Laia, Vilaplana, Eduard, Sala, Isabel, Subirana, Andrea, Querol-Vilaseca, Marta, Carmona-Iragui, María, Illán-Gala, Ignacio, Ribosa-Nogué, Roser, Blesa, Rafael, Haass, Christian, Fortea, Juan, Lleó, Alberto · 2019 · Scientific Reports
Cited by 59

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

The role of innate immunity in dementia with Lewy bodies (DLB) has been little studied. We investigated the levels in cerebrospinal fluid (CSF) of glial proteins YKL-40, soluble TREM2 (sTREM2) and progranulin in DLB and their relationship with Alzheimer’s disease (AD) biomarkers. We included patients with DLB (n = 37), prodromal DLB (prodDLB, n = 23), AD dementia (n = 50), prodromal AD (prodAD, n = 53), and cognitively normal subjects (CN, n = 44). We measured levels of YKL-40, sTREM2, progranulin, Aβ 1–42, total tau (t-tau) and phosphorylated tau (p-tau) in CSF. We stratified the group DLB according to the ratio t-tau/Aβ 1–42 (≥0.52, indicative of AD pathology) and the A/T classification. YKL-40, sTREM2 and progranulin levels did not differ between DLB groups and CN. YKL-40 levels were higher in AD and prodAD compared to CN and to DLB and prodDLB. Patients with DLB with a CSF profile suggestive of AD copathology had higher levels of YKL-40, but not sTREM2 or PGRN, than those without. T+ DLB patients had also higher YKL-40 levels than T−. Of these glial markers, only YKL-40 correlated with t-tau and p-tau in DLB and in prodDLB. In contrast, in prodAD, sTREM2 and PGRN also correlated with t-tau and p-tau. In conclusion, sTREM2 and PGRN are not increased in the CSF of DLB patients. YKL-40 is only increased in DLB patients with an AD biomarker profile, suggesting that the increase is driven by AD-related neurodegeneration. These data suggest a differential glial activation between DLB and AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-44173-8

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 59

Metadata

Authors
Morenas-Rodríguez, E., Alcolea, D., Suárez-Calvet, M., Muñoz-Llahuna, L., Vilaplana, E., Sala, I., Subirana, A., Querol-Vilaseca, M., Carmona-Iragui, M., Illán-Gala, I., Ribosa-Nogué, R., Blesa, R., Haass, C., Fortea, J., & Lleó, A.
Venue
Scientific Reports
Published
2019-05-24
Volume
9
Issue
1
Pages
7803-7803
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2946060189
Cited by
59
References
24
FWCI
3.69
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease. https://app.cochat.ai/papers/10.1038/s41598-019-44173-8
The paper
Morenas-Rodríguez, E., Alcolea, D., Suárez-Calvet, M., Muñoz-Llahuna, L., Vilaplana, E., Sala, I., Subirana, A., Querol-Vilaseca, M., Carmona-Iragui, M., Illán-Gala, I., Ribosa-Nogué, R., Blesa, R., Haass, C., Fortea, J., & Lleó, A. (2019). Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease. Scientific Reports. https://doi.org/10.1038/s41598-019-44173-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.